The first purchase order for Catheter Precision's LockeT device from a reputable healthcare facility like HCA Healthcare is a significant business milestone. It not only validates the product's market acceptance but also sets the stage for future sales and revenue growth. This development is likely to be viewed positively by investors, potentially leading to an uptick in VTAK's stock price in the short term.